secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001493152-26-020410
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric corrects proxy error: reverse split ratio range is 1-for-5 to 1-for-15, not 1-for-50
--------------------------------------------------------------------------------

- Corrected reverse split range from erroneously stated 1-for-50 to correct 1-for-15 in proxy statement.
- Error appeared on proxy card and notice of internet availability; other proposal text was correct.
- Meeting details (May 28, 2026, virtual, all proposals) remain unchanged; supplemental filing made April 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/0001493152-26-020410-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-020410

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer